Oncodesign
Identification
Instrument name
ONCODESIGN
Symbol
ALONC
ISIN code
FR0011766229
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description
Oncodesign specializes in the research and development of drugs for the treatment of cancer. The group provides preclinical pharmacological evaluation services in the oncology field.
Source: Cofisem
Website address
http://www.oncodesign.com
Operation
IPO date
Wed 02/04/2014
IPO type
Initial Public Offering
IPO price
7,34 EUR
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 6.42 - EUR 7.34
Capital raised
12.8